In the previous study, we found that flavonoids and ginsenosides exhibited high eliminate rates of human immunodeficiency virus type 1 (HIV-1) D3-transfected macrophages. Based on these findings, here we synthesized the derivatives of gallic acid, including methyl gallate, methyl 4-O-methyl gallate, methyl 3,4-O-dimethyl gallate, and methyl 3,4,5-O-trimethyl gallate and measured their cellular toxic effects against HIV-1-infected macrophages. Of these, treatment with methyl 4-O-methyl gallate in the presence of lipopolysaccharide (LPS) and cycloheximide (CHX) most effectively eliminated HIV-1-transfected cytoprotective human microglial CHME5 cells and HIV-1-D3-infected human primary macrophages. Furthermore, these strongly inhibited LPS/CHX-induced phosphorylation of phosphoinositide 3-kinase (PI3K), pyruvate dehydrogenase lipoamide kinase isozyme 1 (PDK1), Akt, and glycogen synthase kinase-3β (GSK-3β) in the Tat-transfected cells and HIV-1-D3-infected human primary macrophages. These findings suggest that methyl 4-O-methyl gallate may be a promising candidate for eliminating HIV-1 infected macrophages by blocking PI3K/Akt signaling pathway.
INTRODUCTION
The infection of human macrophages by human immunodeficiency virus type 1 (HIV-1) activates the phosphoinositide 3-kinase (PI3K)/Akt cell survival pathway, resulting in macrophages resisting to cytotoxic attacks, e.g., some HIV-1 antigens such as Tat protein and gp120 activate PI3K/ Akt signaling pathway in macrophages (1, 2) . PI3K/Akt signaling pathway regulates the expression of mammalian target of rapamycin (mTOR) and glycogen synthase kinase-3β (GSK-3β), resulting in the potentiation of cell survival and growth (3) . In addition, the transfection of HIV-1 Tat into microglial CHME5 cells activates the PI3K/Akt signaling pathway by suppressing the expression of phosphatase and tensin homolog (PTEN), which is acting as a negative regulator. The expression of Tat protein from HIV-1 in the human microglial cell line, CHME5 as well as primary human macrophages, activates the PI3K/Akt pathway under the cellular stresses by reducing the level of PTEN, leading to a strong resistance to extracellular stresses such as LPS or nitric oxide (1, 4, 5) . The Tat-transfected cells become resistant to extracellular cytotoxic insults such as LPS (6) .
HIV-1 Tat-expressed microglia in humans becomes long-239 lived HIV-1 reservoirs in the central nervous system (4, 6, 7) , and causes neuronal death and neurodegenerative diseases (8, 9) . Therefore, to control these diseases, many studies have been conducted to eliminate the HIV-1-infected macrophages by searching for synthetic chemicals such as miltefosine (3) , and phytochemicals such as arctigenin (5), oroxylin A and tectorigenin (10) . These eliminated the HIV-1-infected macrophages by inhibiting PI3K/Akt cell survival signaling pathway.
Based on these findings, in the present study, we synthetized the derivatives of gallic acid and confirmed their anti-HIV-1 mechanism in CHME5 cells and primary macrophages. 
MATERIALS AND METHODS

Reagents and antibodies
Gallic acid and its methyl derivatives
Production of HIV-1-D3 particles
Primary macrophages were infected with a HIV-1-D3. Protein Levels of PI3K, p-PI3K, PDK-1, p-PDK-1, Akt, pAkt, GSK-3β, p-GSK-3β, mTOR, p-mTOR and β-actin were assayed as previously described (10) . Immunodetection was carried out using an enhanced chemiluminescence detection kit.
Statistical analysis
Data are indicated as the means ± a standard deviation (S.D.) of at least three replicates. One-way variance analysis and student's t-test were used. A p-value < 0.05 was statistically significant. 
RESULTS
The
